Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

The study published in the Annals of Surgery found that bariatric surgery was linked to a 60% lower risk of kidney disease ...

So what are Ozempic burps, exactly? Read on for the full scoop from a medical expert , plus some sage advice on how best to ...

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

The first reveal of clinical data with Eli Lilly’s injectable triple receptor agonist for obesity suggests that the company could have a big winner on its hands if the drug makes it through to ...

The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and ...